The Nonalcoholic Steatohepatitis Conference is dedicated to the latest trends and developments in Nonalcoholic Steatohepatitis, examining the latest research and development in diagnosis, pathogenesis and treatment of the disease.
The Nonalcoholic Steatohepatitis Conference covers topics such as:
- Challenges in the diagnosis and therapy of NASH
- Novel biomarkers, diagnostic tools, in vivo liver models
- NASH clinical trials
- Preclinical & translational targets for treatment of NASH/ fibrosis
- Role of liver fibrosis in NASH
- Recent updates in NASH pathogenesis
- Cutting edge therapeutic options
- Regulatory landscape pathways
The Nonalcoholic Steatohepatitis Conference brings together:
- Lab teams
- Clinicians
- Translational Researchers
- Hepatologists
- Gastroenterologists
- Clinical Pathologists
- Directors, VPs, Managers and Heads from Biotech, Pharmaceuticals and Healthcare
- Diabetologists
